Y. Xie, L. Yang, Q. Chen et al.
European Journal of Medicinal Chemistry 212 (2021) 113120
4
.6. (9H-fluoren-9-yl)methyl tert-butyl (6-((2-(2-hydroxyethoxy)
(t, J ¼ 4.0 Hz, 2H), 1.83 (d, J ¼ 8.0 Hz, 3H), 1.74e1.40 (m, 15H). 13C
ethyl)amino)-6-oxohexane-1,5-diyl)dicarbamate (2)
3
NMR (CD OD, 100 MHz) (ppm): 175.5, 168.7, 157.8, 155.9, 146.9,
1
45.6, 140.7, 136.2, 131.0, 126.2, 106.8, 80.6, 71.8, 71.0, 69.9, 56.2,
0
þ
N-(3-Dimethylaminopropyl)-N -ethylcarbodiimide hydrochlo-
40.4, 40.0, 33.2, 30.1, 28.8, 24.3, 17.8. HRMS calcd for [MþNa]
ride (230 mg, 1.2 mmol) and N-Hydroxysuccinimide (127 mg,
587.2441; Found 587.2428.
1.1 mmol) were added to a solution of 1 (413 mg, 0.88 mmol) in
anhydrous dichloromethane (2 ml), and the reaction was per-
4.10. 2-amino-4-methylpentanoic acid (5)
formed for 2 h at room temperature. N, N-Diisopropylethylamine
(
1
336 mg, 2.6 mmol) and 2-(2-Aminoethoxy)ethanol (116 mg,
.1 mmol) were then added, and the mixture was reacted overnight
A solution of Fmoc-Leu-OH (3 g, 8.5 mmol) in 20% piperidine in
DMF was reacted at room temperature for 1 h and monitored with
TLC. After reaction finish, cold ethyl ether was added to wash the
furtherly. The solvent was removed under vacuo, the residue was
purified by flash chromatography (DCM/MeOH, 50/1) to afford the
reaction residues and obtained the pure product 5 (1.1 g, 100%
1
1
product 2 as a colorless liquid (254 mg, 52% yield). H NMR (CD
3
OD,
yield). H NMR (CD
3
OD, 400 MHz)
d
(ppm): 3.54e3.51 (m, 1H),
4
00 MHz) (ppm): 7.78 (d, J ¼ 8.0 Hz, 2H), 7.63 (d, J ¼ 8.0 Hz, 2H),
1.79e1.75 (m, 2H), 1.65e1.58 (q, J ¼ 8.0 Hz, 1H), 0.98 (t, J ¼ 8.0 Hz,
7
4
3
.38 (t, J ¼ 8.0 Hz, 2H), 7.30 (t, J ¼ 8.0 Hz, 2H), 4.33 (d, J ¼ 8.0 Hz, 2H),
6H). ESI-MS calcd for [MþNa]þ 154.09; Found 154.3.
.17 (t, J ¼ 8.0 Hz, 1H), 3.99e3.98 (m, 1H), 3.64 (t, J ¼ 4.0 Hz, 2H),
.55e3.47 (m, 4H), 3.37 (t, J ¼ 4.0 Hz, 2H), 3.12e3.08 (m, 2H),
4.11. 2-acetamido-4-methylpentanoic acid (6)
13
3
1.73e1.42 (m, 15H). C NMR (CD OD, 100 MHz) (ppm): 175.4,159.0,
157.9, 145.4, 142.7, 128.8, 128.2, 126.2, 121.0, 80.7, 73.5, 70.6, 67.7,
2
To a solution of Leu-OH (5, 1.1 g, 8.5 mmol) in 70% THF/H O
6
2.3, 56.2, 41.5, 40.4, 33.2, 30.9, 30.6, 28.8, 24.1. ESI-MS calcd for
(80 ml) was added acetic anhydride dropwise and slowly in ice-
batch. The mixtures were monitored with TLC. After reaction fin-
þ
[MþNa] 578.29; Found 578.6.
ish, the volatile was removed to obtain the pure product 6 in a
1
4.7. tert-butyl (6-amino-1-((2-(2-hydroxyethoxy)ethyl)amino)-1-
quantitative yield. H NMR (DMSO, 400 MHz)
d
(ppm): 12.48 (br,
oxohexan-2-yl)carbamate (3)
1H), 8.09 (d, J ¼ 8.0 Hz, 1H). 4.21e4.16 (m, 1H), 1.83 (s, 3H),
13
1
.67e1.57 (m, 1H), 1.50e1.47 (m, 2H), 0.89e0.83 (m, 6H). C NMR
A solution of 2 (254 mg, 0.46 mmol) in piperidine/DCM (1:1,
ml) was reacted at room temperature and monitored with TLC.
After completion of the reaction, cold ethyl ether was added to
(DMSO, 100 MHz) (ppm): 174.3, 169.2, 50.1, 24.3, 22.8, 22.3, 21.3.
ESI-MS calcd for [M ꢂ H] 172.11; Found 172.10.
-
1
wash the reaction residues and obtained the product 3 as a light
4.12. 2-(2-acetamido-4-methylpentanamido)acetic acid (7)
1
yellow oil (114 mg, 75% yield). H NMR (CD
3
OD, 400 MHz)
d
(ppm):
4
3
9
.02e3.94 (m, 1H), 3.63 (t, J ¼ 4.0 Hz, 2H), 3.50 (t, J ¼ 4.0 Hz,4H),
It was synthesized on a 0.5 mmol scale Fmoc-Gly-Wang resin
(capacity, 0.41 mmol/g). To the swelled and pre-deprotected Gly-
Wang resin in DMF were added 2-(1H-benzotriazole-1-yl)-1,1,3,3-
.38e3.32 (m, 2H), 2.91 (t, J ¼ 4.0 Hz, 2H), 1.71e1.53 (m, 6H), 1.40 (s,
H). ESI-MS calcd for [MþH]þ 334.23; Found 334.6.
tetramethyluroniumhexafluorophosphate
(HBTU,
948
mg,
4.8. (E)-tert-butyl (6-(but-2-enamido)-1-((2-(2-hydroxyethoxy)
2.5 mmol), 1-Hydroxybenzotriazole hydrate (HOBt, 338 mg,
ethyl)amino)-1-oxohexan-2-yl)carbamate (4)
2.5 mmol), 6 (433 mg, 2.5 mmol) and N, N-Diisopropylethylamine
(DIEA, 646 mg, 5 mmol). The mixtures were reacted for 2 h, fol-
3
(83 mg, 0.25 mmol) was dissolved in DMF/acetonitrile mixture
lowed by cleavage by trifluoroacetic acid, precipitation in ethyl
ether to obtain the crude peptide. With further purification by
(
1:3, 1.2 ml) in ice-bath. To this solution was added crotonic an-
hydride (50 mg, 0.32 mmol) slowly. After completion of the reac-
tion and removal of the solvents, the crude product was purified
preparative HPLC, the pure product 7 was obtained (60 mg, 52%
1
yield). H NMR (CD
3
OD, 400 MHz)
d
(ppm): 4.44e4.41 (m, 1H),
with column chromatography (DCM/MeOH, 100/1e30/1) to yield 4
3.95e3.82 (m, 2H), 1.98 (s, 3H), 1.70e1.65 (m, 1H), 1.63e1.53 (m,
1
-
(
(
(
49 mg, 49% yield). H NMR (CD
3
OD, 400 MHz)
d
(ppm): 6.80e6.70
2H), 0.96e0.91 (m, 6H). ESI-MS calcd for [M ꢂ H] 229.13; Found
m, J
m,1H), 3.65 (t, J ¼ 4.0 Hz, 2H), 3.52 (t, J ¼ 4.0 Hz, 4H), 3.42e3.35 (m,
H), 3.21 (t, J ¼ 4.0 Hz, 2H), 1.83 (d, J ¼ 4.0 Hz, 3H), 1.76e1.43 (m,
1
¼ 4.0 Hz, J
2
¼ 16.0 Hz, 1H), 5.91 (d, J ¼ 16.0 Hz, 1H), 4.02e3.94
229.2.
2
4.13. 2-amino-6-(but-2-enamido)-N-(2-(2-hydroxyethoxy)ethyl)
hexanamide (8)
13
15H). C NMR (CD
3
OD, 100 MHz) (ppm): 175.3, 168.6, 157.8, 140.6,
1
1
26.2, 80.6, 73.5, 70.5, 62.3, 56.1, 40.4, 40,1, 33.2, 30.2, 28.8, 24.3,
7.9. ESI-MS calcd for [MþNa]þ 424.25; Found 424.5.
A solution of 4 (70 mg, 0.17 mmol) in trifluoroacetic acid/DCM
(1:1) was reacted at room temperature and monitored with TLC.
4.9. (E)-tert-butyl (6-(but-2-enamido)-1-((2-(2-((7-nitrobenzo[c]
After reaction finish, cold ethyl ether was added to wash the re-
[
1,2,5]oxadiazol-4-yl)oxy)ethoxy)ethyl)amino)-1-oxohexan-2-yl)
action residues two times and the pure product 8 was obtained in
1
carbamate (KTcr-I)
quantitative yield. H NMR (CD
3
OD, 400 MHz)
d
(ppm): 6.81e6.72
(
m, J
1
¼ 8.0 Hz, J ¼ 16.0 Hz, 1H), 5.92 (d, J ¼ 16.0 Hz, 1H), 4.52e4.50
2
NBD-F (29 mg, 0.16 mmol) and N, N-Diisopropylethylamine
(m, 1H), 3.85e3.75 (m, 2H), 3.68e3.52 (m, 4H), 3.46e3.37 (m, 2H),
3.23 (t, J ¼ 8.0 Hz, 2H), 1.83 (m, J ¼ 8.0 Hz, 5H), 1.59e1.52 (m, 2H),
1.44e1.37 (m, 2H). ESI-MS calcd for [MþH]þ 302.20; Found 302.60.
(
0
40 mg, 0.31 mmol) were added to a solution of 4 (49 mg,
.12 mmol) in anhydrous DCM/DMF (3:1). The mixture was stirred
overnight at room temperature. After completion of the reaction
and solvent removal under reduced vacuo, the residue was purified
by flash column chromatography (DCM/MeOH, 50/1e20/1), fol-
4.14. 2-(2-(2-acetamido-4-methylpentanamido)acetamido)-6-((E)-
but-2-enamido)-N-(2-(2-hydroxyethoxy)ethyl)hexanamide (9)
lowed by preparative TLC, to afford the product KTcr-I as a yellow
1
solid (16 mg, 24% yield). H NMR (CD
(
3
OD, 400 MHz)
d
(ppm): 8.64
¼ 8.0 Hz,
1-Hydroxybenzotriazole hydrate (HOBt, 18 mg, 0.13 mmol) and
N-(3-Dimethylaminopropyl)-N -ethylcarbodiimide hydrochloride
(EDCI, 25 mg, 0.13 mmol) were added to a solution of compound 7
(22 mg, 0.1 mmol) in anhydrous DMF (0.5 ml), and the mixture was
0
d, J ¼ 8.0 Hz, 1H), 6.99 (d, J ¼ 8.0 Hz, 1H), 6.77e6.67 (m, J
1
J
2
¼ 16.0 Hz, 1H), 5.88 (d, J ¼ 16.0 Hz, 1H), 4.57 (t, J ¼ 4.0 Hz, 2H),
3
.98e3.94 (m, 3H), 3.65 (t, J ¼ 4.0 Hz, 2H), 3.49e3.33 (m, 2H), 3.17
6